No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women
Elevated Blood Pressure · Perimenopause
De qué trata este estudio
El registro no identifica actualmente este estudio como reclutando. Consulta su estado antes de planificar una evaluación.
- Tipo de estudio
- De intervención
- Fase
- No aplica
- Rango de edad
- 45 años - 50 años
- Sexo admitido
- Femenino
- Voluntarios sanos
- No aceptados
- Participantes
- 40 Estimado
Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.
Las explicaciones y la navegación están en español. Los textos proporcionados por el registro, incluidos títulos, resúmenes y criterios, se conservan en su idioma original. Puedes pedir orientación en español a WCR.
Acerca de la investigación
This study will test the effects of a physical activity intervention among midlife Hispanic women.
Leer la descripción completa
The menopausal transition in midlife is a critical juncture where women experience life transitions and adverse physiological and psychological changes that increase the risk for hypertension and cardiovascular diseases in later life. Physical activity improves blood pressure, biomarkers of hypertension, sleep, mood, and well-being; however, Hispanic women meet physical activity recommendations at lower levels than non-Hispanic White women. The investigator will examine the feasibility of the physical activity intervention among sedentary midlife Hispanic women in the menopausal transition with elevated blood pressure, exploring changes in physical activity and health.
¿Quién podría participar?
La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.
Inclusion Criteria:
1. Female
2. Hispanic by self-report
3. Able to speak and read English
4. Sedentary
5. Age 45-50
6. Diagnosed with elevated blood pressure or objectively measured systolic blood pressure 120-139 mmHg and/or diastolic blood pressure 80-89 mmHg averaged from ≥ 2 measures on ≥ 2 outpatient visits
7. Symptoms consistent with the menopause transition (persistent difference of ≥7 days in the length of consecutive cycles; persistence is defined as recurrence within 10 cycles of the first variable length cycle)
8. Apparently healthy
9. Self-reported ability to engage in moderate intensity physical activity
10. Access to a smart device that is compatible with a Fitbit application
Exclusion Criteria:
1. Self-reported physical activity of ≥150 minutes per week
2. Answered yes to any question on the Physical Activity Readiness (PAR-Q+) questionnaire
3. Post-menopausal (12-months without a menstrual cycle)
4. Diagnosed hypertension
5. Cardiovascular, respiratory, neurological, renal, endocrine, gastrointestinal and/or psychiatric diseases, or any cancers
6. Previous hysterectomy, oophorectomy, and/or uterine ablation
7. Medication to treat hypertension, elevated glucose, cholesterol, depression, anxiety, and insomnia
8. Hormonal medication via any route or implants
9. Tamoxifen
10. Pregnant, planning to become pregnant, or breastfeeding
11. Planning to move out of the Galveston/Houston area in the next 18 months
12. Current participation in another physical activity study or program
Tratamiento, grupos y participación
El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.
- Asignación
- No aplica
- Enmascaramiento
- Sin enmascaramiento
Physical activity intervention
Multi-level intervention to increase physical activity
Behavioral: Physical activity intervention
Physical activity intervention BEHAVIORAL
Physical activity
Qué evalúan los investigadores
Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.
Medidas principales
Days the activity monitor was worn
Plazo: Baseline to 6-months
Objectively measured days the wearable activity monitor was worn during the intervention period
Medidas secundarias
Physical activity as measured by minutes of moderate-vigorous intensity physical activity at 6 months
Plazo: Baseline to 6-months
Mean daily minutes of moderate-vigorous intensity physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of moderate-vigorous intensity physical activity at 6 months
Plazo: Baseline to 12-months
Mean daily minutes of moderate-vigorous intensity physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of moderate intensity physical activity at 6 months
Plazo: Baseline to 6-months
Mean daily minutes of moderate intensity physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of moderate intensity physical activity at 6 months
Plazo: Baseline to 12-months
Mean daily minutes of moderate intensity physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of vigorous intensity physical activity at 6 months
Plazo: Baseline to 6-months
Mean daily minutes of vigorous intensity physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of vigorous intensity physical activity at 6 months
Plazo: Baseline to 12-months
Mean daily minutes of vigorous intensity physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of light intensity physical activity at 6 months
Plazo: Baseline to 6-months
Mean daily minutes of light intensity physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of light intensity physical activity at 6 months
Plazo: Baseline to 12-months
Mean daily minutes of light intensity physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of total physical activity at 6 months
Plazo: Baseline to 6-months
Mean daily minutes of total physical activity taken from accelerometers for a 7 day period
Physical activity as measured by minutes of total physical activity at 6 months
Plazo: Baseline to 12-months
Mean daily minutes of total physical activity taken from accelerometers for a 7 day period
Systolic blood pressure
Plazo: Baseline to 6-months
Change in systolic blood pressure (mmHg)
Systolic blood pressure
Plazo: Baseline to 12-months
Change in systolic blood pressure (mmHg)
Diastolic blood pressure
Plazo: Baseline to 6-months
Change in diastolic blood pressure (mmHg)
Diastolic blood pressure
Plazo: Baseline to 12-months
Change in diastolic blood pressure (mmHg)
Otras medidas
Abdominal circumference
Plazo: Baseline to 6-months
Change in abdominal circumference (cm)
Abdominal circumference
Plazo: Baseline to 12-months
Change in abdominal circumference (cm)
Body mass index
Plazo: Baseline to 6-months
Change in body mass index (kg/m2)
Body mass index
Plazo: Baseline to 12-months
Change in body mass index (kg/m2)
Revisa las tablas completas y sus limitaciones en el registro oficial.
Abrir resultados oficiales ↗Centros de investigación (1)
El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.
1 centros
University of Texas Medical Branch, GalvestonGalveston, Texas, United StatesEstado desconocido
Equipo y fechas
- Patrocinador principal
- The University of Texas Medical Branch, Galveston
- Inicio del estudio
- 20 abr 2027 Estimado
- Finalización primaria
- 2029-01 Estimado
- Finalización del estudio
- 2029-01 Estimado
- Primera publicación
- 19 abr 2024 Real
- Última actualización
- 10 nov 2026 Real
Contactos oficiales del estudio
Título oficial del estudio
No Time to Pause: Physical Activity to Improve Health and Well-being of Midlife Hispanic Women During the Menopausal Transition
Consulta a Wellness Clinical Research
Tu mensaje va a WCR, incluso si otra organización realiza este estudio. WCR puede orientarte, pero podría no realizar este estudio, tener acceso a su equipo ni poder inscribirte.
Fuente: API v2 de ClinicalTrials.gov. Patrocinadores e investigadores envían la información. La NLM no aprueba la seguridad ni la ciencia de todos los estudios registrados. Aviso del registro.
Consultado: 11 nov 2026 · Última actualización del registro: 10 nov 2026